Microsoft (MSFT) Stock Trend Analysis
Companies / Microsoft Jun 03, 2021 - 11:19 AM GMT3. MICROSOFT - $252.5
Microsoft is up 12% since my last update, and is now over priced on an EC of 70, against fair value of 55. Unless I am missing something, the stock needs to consolidate it's powerful advance before considering going higher as it is not healthy for a stock to keep becoming more expensive. Maybe it's the 2.1% dividend yield that's attracting investors? But on an EC of 70 it is a little expensive for my taste. Not a good buy at current levels so the Buy % is 35%.
Downside during any correction appears limited to $230. Below which are a series of previous highs from 224 to 227. So there is heavy support under Microsoft. It's difficult to see Microsoft trading much lower than that. Therefore a probable buying level for MSFT is $230.
TOP AI Mega-trend Stocks Analysis
The rest of this extensive analysis that concludes in buying levels for AI tech stocks. AI Stock Buying Levels, Ratings, Valuations and Trend Analysis into Market Correction has first been made available to Patrons who support my work.
Contents:
- TESLA
- Cathy Wood ARK Funds CRASH!
- India Apocalypse Heralds Catastrophe for Pakistan and Bangladesh
- Covid-19 in Italy in August 2019!
- Stock Market Early Summer Correction Trend Forecast
- Stocks Expensive or Cheap Indicator (EC)
- AI Stock Buy % Rating Review
- 1. GOOGLE - $2398
- 2. AMAZON - $3312
- 3. MICROSOFT - $252.5
- 4. APPLE - $130
- 5. FACEBOOK - $320
- 6. NVIDIA - $592.5
- 7. AMD - $78.8
- 11. IBM - $145.5
- 12. INTEL - $57.7
- AI Stocks Buying Levels Update May 2021
- So what am I going to do
- GPU Mining FREE MONEY!
- CHIA Crypto Farming with Your Hard Drives Insanity!
So for immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.
Including my most recent analysis: Five More Small Cap Bio and Tech Stocks to Invest for 2021 and Beyond!
- Invest and Forget
- Stock Market Early Summer Correction Review
- AI Stocks Strength vs Weakness
- RAMPANT MONEY PRINTING INFLATION BIG PICTURE!
- HIGH RISK STOCK BUYING LEVELS
- RISK RATINGS
- WESTERN DIGITAL - WDC $71 - CHIA! - Risk 1
- Life Sciences Biotech Smaller Cap High Risk Stocks Investing Binge
- Biotech stock 1 - Cheap Low Risk Pharma - Risk 1
- Biotech stock 2 - HIGH RISK GENE EDITING - Risk 9
- Biotech stock 3 - Low Risk 2
- Biotech stock 4 - X10 for Max Risk 10
- High Risk Stocks Portfolio Buying Levels
- Covid India Black Mold Epidemic
- Bitcoin and Raven Coin Buying Levels
My analysis schedule includes:
- Bitcoin Trend Forecast - 50% done
- More X10 Biotech Tech Stocks - 40% done
- UK House Prices Trend Analysis - 10% done
- How to Get Rich! - 70% done
- US Dollar and British Pound analysis
- Gold and SIlver Price Analysis
And ensure you are subscribed to my ALWAYS FREE newsletter for my next in-depth analysis.
Your analyst locked an loaded for the next AI stocks discount sale that should soon start to materialise as per my forecast of 11th Feb..
Nadeem Walayat
Copyright © 2005-2021 Marketoracle.co.uk (Market Oracle Ltd). All rights reserved.
Nadeem Walayat has over 30 years experience of trading derivatives, portfolio management and analysing the financial markets, including one of few who both anticipated and Beat the 1987 Crash. Nadeem's forward looking analysis focuses on UK inflation, economy, interest rates and housing market. He is the author of five ebook's in the The Inflation Mega-Trend and Stocks Stealth Bull Market series that can be downloaded for Free.
Nadeem is the Editor of The Market Oracle, a FREE Daily Financial Markets Analysis & Forecasting online publication that presents in-depth analysis from over 1000 experienced analysts on a range of views of the probable direction of the financial markets, thus enabling our readers to arrive at an informed opinion on future market direction. http://www.marketoracle.co.uk
Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any trading losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any trading activities.
Nadeem Walayat Archive |
© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.